Keywords
cardiovascular diseases, hypertension, diabetes mellitus, dyslipidemia, primary healthcare
How to Cite
Abstract
Non-communicable diseases (NCDs), particularly cardiovascular diseases (CVD), hypertension, diabetes mellitus (DM), and dyslipidemia (DL), are the leading causes of global mortality, accounting for 71% of deaths annually. Early detection is critical to reducing their burden, especially in low- and middle-income countries (LMICs). This paper explores the pivotal role of community health nurses (CHNs) in identifying these conditions within populations covered by health insurance packages. Globally, CVD claims 17.9 million lives yearly, with hypertension affecting 22% of adults. Leveraging insurance-covered services, CHNs facilitate screening, risk factor identification, and timely intervention. This review highlights their contributions and the need for integrated health system support to enhance NCD management.
References
1. Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254-e743
2. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. GBDNHLBI-JACC Global burden of cardiovascular diseases writing group. Global burden of cardiovascular diseases and risk factors, 1990–2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982–3021. doi: 10.1016/j.jacc.2020.11.010.
3. Malachias MVB, Souza WKSB, Plavnik FL, Rodrigues CIS, Brandão AA, Neves MFT, et al. 7th Brazilian Arterial Hypertension Guidelines. Arq Bras Cardiol. 2016;107(3):1–83.
4. World Health Organization (WHO) Noncommunicable diseases country profiles 2018. Geneva: World Health Organization; 2018. [2019 Dec 09].
5. Ministério da Saúde (BR) Secretaria de Vigilância em Saúde. Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde . Vigitel Brasil 2018: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico. Brasília: Ministério da Saúde; 2019. [2019 Dec 09].
6. Hollander W. Role of hypertension in atherosclerosis and cardiovascular disease. Am J Cardiol. 1976;38(6):786–800.
7. Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. The Lancet. 2020;396(10258):1204–22.
8. Roth GA, Mensah GA, Johnson CO, et al. Global Burden of Cardiovascular Diseases and Risk factors, 1990–2019: Update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982– 3021.
9. Joseph P, Leong D, McKee M, et al. Reducing the Global Burden of Cardiovascular Disease, Part 1: the epidemiology and risk factors. Circ Res. 2017;121(6):677–94.
10. Rhee EJ. Prevalence and current management of cardiovascular risk factors in Korean adults based on fact sheets. Endocrinol Metab (Seoul) 2020;35:85–94.
11. Hedayatnia M, Asadi Z, Zare-Feyzabadi R, Yaghooti-Khorasani M, Ghazizadeh H, Ghaffarian-Zirak R, Nosrati-Tirkani A, Mohammadi-Bajgiran M, Rohban M, Sadabadi F, et al. Dyslipidemia and cardiovascular disease risk among the MASHAD study population. Lipids Health Dis. 2020;19:42.
12. Darroudi S, Saberi-Karimian M, Tayefi M, Arekhi S, Motamedzadeh Torghabeh A, Seyedzadeh Sani SMR, Moohebati M, Heidari-Bakavoli A, Ebrahimi M, Azarpajouh MR, et al. Prevalence of combined and noncombined dyslipidemia in an Iranian population. J Clin Lab Anal. 2018;32:e22579.
13. Borén J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, Daemen MJ, Demer LL, Hegele RA, Nicholls SJ, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2020;41:2313–2330.
14. Libby P, Ridker Paul M, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–1143.
15. Thrainsdottir IS, Aspelund T, Thorgeirsson G, Gudnason V, Hardarson T, Malmberg K, Sigurdsson G, Rydén L. The association between glucose abnormalities and heart failure in the population-based Reykjavík Study. Diabetes Care. 2005;28:612.
This work is licensed under a Creative Commons Attribution 4.0 International License.